Stroke

Citations 101-110 of 196 total displayed.

Past content (since Apr 1998):

Letters
Oral Antiplatelet Therapy

Richard A. Bernstein; Gregory W. Albers
JAMA 2005; 293: 793-a-794-a. [Extract] [Full text] [PDF]  

Letters
Oral Antiplatelet Therapy

Javier Borja
JAMA 2005; 293: 793. [Extract] [Full text] [PDF]  

Letters
Oral Antiplatelet Therapy—Reply

Huyen Tran; Sonia S. Anand
JAMA 2005; 293: 794-795. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Officials Halt NSAID Prevention Trials

Tracy Hampton
JAMA 2005; 293: 664-665. [Extract] [Full text] [PDF]  

Original Contributions
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation: A Randomized Trial

SPORTIF Executive Steering Committee for the SPORTIF V Investigators
JAMA 2005; 293: 690-698. [Abstract] [Full text] [PDF]  

Original Contributions
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation

Cara L. O’Brien; Brian F. Gage
JAMA 2005; 293: 699-706. [Abstract] [Full text] [PDF]  

Original Contributions
Maternal and Infant Characteristics Associated With Perinatal Arterial Stroke in the Infant

Janet Lee; Lisa A. Croen; Kendall H. Backstrand; Cathleen K. Yoshida; Louis H. Henning; Camilla Lindan; Donna M. Ferriero; Heather J. Fullerton; A. J. Barkovich; Yvonne W. Wu
JAMA 2005; 293: 723-729. [Abstract] [Full text] [PDF]  

Health Agencies Update
Sickle-Cell Transfusions

Tracy Hampton
JAMA 2005; 293: 415-a. [Extract] [Full text] [PDF]  

Letters
Thrombolysis for Acute Stroke

Jerry J. Svoboda
JAMA 2005; 293: 421-b-422-b. [Extract] [Full text] [PDF]  

Letters
Predictors of Lack of Improvement After Thrombolytic Stroke Therapy—Reply

Gustavo Saposnik; Bryan Young; Vladimir Hachinski
JAMA 2005; 293: 421-a. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20